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The ability of proteins to aggregate to form well-organized β-sheet rich amyloid fibrils
is increasingly viewed as a general if regrettable property of the polypeptide chain.
Aggregation leads to diseases such as amyloidosis and neurodegeneration in humans
and various mammalian species but is also found in a functional variety in both
animals and microbes. However, there are to our knowledge no reports of amyloid
formation in plants. Plants are also the source of a large number of aggregation-
inhibiting compounds. We reasoned that the two phenomena could be connected
and that one of (many) preconditions for plant longevity is the ability to suppress
unwanted protein aggregation. In support of this, we show that while protein extracts
from the sugar maple tree Acer saccharum fibrillate readily on their own, this process
is efficiently abolished by addition of small molecule extracts from the same plant.
Further analysis of 44 plants showed a correlation between plant longevity and ability
to inhibit protein aggregation. Extracts from the best performing plant, the sugar maple,
were subjected to chromatographic fractionation, leading to the identification of a large
number of compounds, many of which were shown to inhibit aggregation in vitro. One
cautious interpretation is that it may have been advantageous for plants to maintain an
efficient collection of aggregation-inhibiting metabolites as long as they do not impair
metabolite function. From a practical perspective, our results indicate that long-lived
plants may be particularly appropriate sources of new anti-aggregation compounds with
therapeutic potential.
Keywords: plant extracts, plant longevity, protein aggregation, inhibitors of aggregation, aggregate toxicity,
α-synuclein, beta amyloid
Abbreviations: αSN, α-synuclein; DCFH-DA, 2′,7′-dichlorodihydrofluorescein diacetate; DMPG, 1,2-dimyristoyl-
sn-glycero-3-[phospho-rac-(1-glycerol)]; DOPG, 1,2-dioleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]; EGCG,
epi-gallocatechin gallate; MTT, 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide; TEM, transmission
electron microscopy; ThT, thioflavin T.
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INTRODUCTION
Since the first discovery of plaque in the brains of patients
suffering from Alzheimer’s disease (Masters et al., 1985),
a number of proteins have been shown to form insoluble
β-sheet-rich structures called amyloid or fibrils under
physiological conditions (Chiti and Dobson, 2006). Among
these are proteins related to common diseases of lifestyle and
aging such as type II diabetes (Pillay and Govender, 2013),
Alzheimer’s disease, and Parkinson’s disease (Poggiolini et al.,
2013) as well as rare genetic disease such as FAS4 mediated
corneal dystrophy (Han et al., 2010; Stenvang et al., 2018). In
addition, a growing number of microbial organisms have been
shown to form functional amyloid (Otzen and Nielsen, 2008;
Dueholm et al., 2013). Amyloid formed by proteins such as CsgA
(Escherichia coli) (Chapman et al., 2002) and FapC (Pseudomonas
sp.) (Dueholm et al., 2010) strengthens biofilms and promotes
cell–cell communication, while fungal hydrophobins can form
two-dimensional amphipathic amyloid films at air–water
interfaces that allow growing fungi to overcome interfacial
tension as well as providing immune-evasive cover (Bayry et al.,
2012). The widespread occurrence of fibrillation has prompted
the hypothesis that fibrillation of proteins is a normal (“generic”)
property (Dobson, 1999) and in fact may represent a more stable
form than the monomeric folded state (Baldwin et al., 2011).
Nevertheless, to date there are very few cases of protein fibril
formation in plants, and with few exceptions such as the rubber
latex protein Hevb1 (Berthelot et al., 2012), the few reports
available do not represent authentic fibrillation of endogenous
proteins in planta (Antonets and Nizhnikov, 2017). Examples
limit themselves to a tobacco plant expressing a foreign protein
(from maize) in the chloroplast (Villar-Pique et al., 2010), a
coconut antimicrobial peptide which can fibrillate in aqueous
buffer (Gour et al., 2016), a soya β-conglycinin subunit which
fibrillates in vitro after heat treatment (Wang et al., 2011), and a
protein fragment that fibrillates in vitro (Garvey et al., 2013).
In contrast, there is an extensive literature on the
fibrillation-inhibiting effects of plant extracts, including
both those consumed as part of a healthy diet (Modi et al., 2015;
Casamenti and Stefani, 2017) and others found in traditional
Eastern (Rajan et al., 2015; Liu et al., 2016; Malishev et al., 2017)
and Western (Tunón, 1995; Lobbens et al., 2016) medicines.
A recent review (Velander et al., 2017) concluded that more than
half of the 72 known natural product inhibitors of aggregation
were polyphenols (e.g., flavonoids, anthraquinones, alkaloids,
and terpenes), and included compounds such as oleuropein and
oleocanthal from olive oil, resveratrol (from fruit and red wine),
curcumin (from turmeric), as well as EGCG and myricetin (green
tea). These molecular groups are also among the best performers
in broader surveys spanning different chemical classes (Masuda
et al., 2006). Interestingly, the vast majority of the inhibitors
are found in perennial spices (Ono et al., 2004; Ishigaki et al.,
2013) and tea (Palhano et al., 2013). The shorter-lived annual
crops do not appear to harbor the same inhibitory components.
A study comparing ethyl acetate extracts from vegetables and
spices confirmed that spices are much more effective than the
short-living vegetables (Fuentes et al., 2016). The very absence
of such data in general might indicate that these otherwise
ubiquitous plants have few or no such inhibitors.
The differences observed between extracts of annual and
perennial plants prompted our investigation of the relationship
between plant longevity and fibrillation inhibition. We reasoned
that the absence of fibrillation in plants is caused by the presence
of small-molecule fibrillation inhibitors, particularly in long-lived
plants. (We emphasize that we do not claim that the primary
evolutionary driving force for the development of these small
molecules in plants is their anti-aggregation properties, but
that such properties could constitute collateral benefits in terms
of, e.g., longevity and could from a pragmatic view be useful
sources of new fibrillation inhibitors.) As a corollary, in the
absence of fibrillation inhibitors, plant proteins should be able to
fibrillate in vitro under the same conditions as many mammalian
proteins. Here, we examine this hypothesis. We start by showing
that plant proteins can indeed fibrillate on their own but are
inhibited by small molecule extracts from the same plant. We
then analyze extracts from a large number of different plants
to examine the correlation between longevity and the ability
to inhibit fibrillation of model proteins. Finally, we identify a
number of inhibitors in the extract of the most promising plant
candidate, several of which have already been documented to act
against fibrillation. We find that there is a certain tendency for
metabolites from longer lived plants to be particularly efficient
at inhibiting protein aggregation, although there is unlikely to
be a simple causal relationship since some short-lived plants
also show efficient aggregation inhibition. Nevertheless, whatever
the evolutionary underpinnings, our anti-aggregation tests of
plant extracts as a simple but effective source of new potential
aggregation inhibitors.
MATERIALS AND METHODS
Materials
All chemicals were of the highest purity possible and were
from Sigma–Aldrich unless otherwise stated. Deuterated NMR
solvents were from Goss Scientific (Crewe, United Kingdom).
Aβ peptide and amylin peptide were purchased from Chinese
Peptide at 95% purity and verified by in-house MALDI-TOF.
αSN was prepared recombinantly from E. coli as described
(Lorenzen et al., 2014a). All plant material was obtained from the
Aarhus Botanical Gardens (Table 1). We saw similar inhibitory
activity for A. saccharum leaves harvested in the spring and the
fall. We avoided harvesting mature spring leaves (i.e., not light
green) and senescent fall leaves.
Small Molecule Extraction
Around 2 mL of plant material was ground in liquid nitrogen
and transferred to one or more 2 mL Eppendorf tubes, which
were then filled with acetone (or other solvent as detailed below)
and heated up to 60◦C for 15 min, followed by overnight
incubation at 4◦C. The samples were centrifuged for 10 min
at 16,000 g and the supernatant collected. The pellet was again
washed with acetone or other solvent, incubated for 15 min and
centrifuged for 10 min at 16,000 g, and the supernatant was
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TABLE 1 | Dosage of plant extract required to completely inhibit the fibrillation of
1 mg/mL αSNa.
Plant Dosage per
150 µl well
(µl)
Minimum
effective mass
(mme) per 150 µl
well (µg)b
mme relative to
total inhibition
with EGCGc
Acer saccharum 1 9.4 0.20
Acer saccharinum 1 17 0.36
Pseudosuga menizies 10 169 3.6
Eucalyptus globolus 10 67 1.4
aComplete inhibition defined as having a ThT level that does not significantly exceed
that of the ThT fluorescence level seen in the lag time of the control experiment (αSN
without any extract). bBased on vacuum drying and weighing of 500 µl extract
(contribution from buffer subtracted). cWeight required for total inhibition relative to
that required for total inhibition with EGCG.
added to the previous extract. The supernatant was evaporated
under vacuum overnight and redissolved in 2 mL of 100 mM
Tris buffer pH 8.5. The sample was filtered through a 0.2 µL
filter, followed by a 3 kDa amicon spin filter. All extracts were
stored at −20◦C. For initial fibrillation inhibition assays used
to screen the 49 different organisms, the extract was suspended
in a volume equivalent to the original volume of plant tissue,
and 10 µL hereof were added to a final volume of 150 µL in
the plate. This 15-fold dilution was used in all plant extracts,
unless otherwise specified. For dose–response studies with four
selected plants (A. saccharum, Acer saccharinum, Pseudotsuga
menziesii, and Eucalyptus globolus) volumes between 0.25 and
10 µl were used. Regarding choice of solvent for extraction,
we note that we attempted extraction both with ethanol, water,
acetone, 50% acetone/water (v/v), and 80% ethanol/water (v/v).
Acetone extract was much more potent than the other extracts
in terms of inhibitory properties; further, HPLC analysis of the
different extracts revealed the same peaks across the different
extraction methods, but with the acetone extract containing far
higher concentrations. Finally, acetone was the most volatile
solvent, making it the easiest to evaporate.
Fractionation of Acer saccharum Extract
The small molecule extract was fractionated on a reverse phase
Jupiter C18 (250 × 10 mm) column using a gradient of 5–35%
acetonitrile over the first 45 ml, followed by a 35–90% gradient
of acetonitrile over 5 ml and 90% acetonitrile over the next
5 ml. The other mobile phase was demineralized water; 0.1%
trifluoroacetic acid was present in both phases and a flow rate of
1 ml/min was used.
Purification of Plant Protein
Acer saccharum (Sugar maple) leaves were ground under liquid
nitrogen with a mortar and pestle until a 50 mL tube was filled
with ground material (uncompressed). The tube was then filled
with a solution containing 1 mM EDTA, 4 mM DTT, 2 mM PMSF,
0.1% Tween 20 and 2% polyvinylpyrrolidone (PVP), and 100 mM
Tris buffer pH 8.5 and incubated on a shaker at 37◦C for 1 h.
The material was centrifuged at 9,000 g for 20 min to pellet plant
material after which the supernatant was filtered through a coffee
filter and ultracentrifuged at 150,000 g for 1 h. The supernatant
was filtered sequentially through filters of pore size 2, 0.45, and
0.1 µm using a vacuum filtration system. The buffer was replaced
with 100 mM Tris pH 8.5 through three rounds of concentration
to 1/10 volume with an Amicon stirred cell filtration system with
a 3 kDa filter, followed by dilution to the original volume. In
the final round, the resultant product was volume-reduced to
5 mL and fractionated on a 24 mL Superose 6 column; 0.25 ml
fractions were collected and concentrated fivefold using 3 kDa
cut-off Millipore spin filters.
Extraction of Insoluble Plant Protein
Aggregates
In order to extract the insoluble proteins from Acer leaves,
2 g A. saccharum leaves were thoroughly pulverized in liquid
nitrogen and then incubated with 50 ml of extraction buffer
(20 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1 mM PMSF) at
37◦C for 15 min. To remove cell debris, the homogenate was
centrifuged at 100 g for 15 min and filtered through a coffee
filter. RNAase and DNAase 1 mg/ml were added and the mixture
was incubated at 37◦C for 30 min. Protein aggregates were
separated by centrifugation at 8,000 g for 15 min at 37◦C and
the supernatant was discarded. The aggregates were washed once
with the same buffer containing 0.5% Triton X-100 and twice
with sterile PBS. The pellet was saved and kept at −20◦C until
analysis. The frozen pellets were resuspended in extraction buffer.
Fibrillation of Proteins
Plant proteins were diluted to 1 mg/ml [using an average
extinction coefficient at 280 nm of 1.0/(mg ml−1 cm−1)] in
100 mM Tris pH 8.5 and incubated with 40 µM ThT at 37◦C
(based on a stock of 5 mM ThT in ethanol). Plate-reader-based
fibrillation of individual proteins was carried out a concentration
of 1 mg/ml αSN, 40µM Aβ peptide (from a 6 mM stock in DMSO
based on A280), and 10 µM amylin (dissolved in 100 mM Tris pH
8.5 at 100 µM). For all four protein groups, each well was filled
with 150 µl solution including 40 µM of ThT, 100 mM Tris-Cl
pH 8.5, and different amounts of plant extract or individual plant
inhibitors. Plant proteins and αSN were fibrillated in a Genios Pro
(Tecan, Männedorf, Switzerland) plate reader (five reads per data
point with 40 µs integration time, reads every 12 min including
10 min orbital shaking at 37◦C with one glass bead), while Aβ and
amylin (which did not require shaking to induce fibrillation) were
fibrillated in a Varioscan flash plate reader (reading every 10 min,
bottom reads, 12 nm bandwidth, measurements time 100 ms
without shaking or glass beads). For both readers, excitation
was at 448 nm and emission at 485 nm. After fibrillation, the
solution was centrifuged at 50,000 g for 1 h and the pellet used
for EM visualization.
Procedure for Incubation With Seeds
Two to four milligrams/milliliter αSN was allowed to fibrillate to
completion by incubation at 37◦C with 200 rpm shaking for 48 h.
Afterward, the fibrils were centrifuged for 30 min at 16,000 g on
a bench top centrifuge. αSN concentration was measured in the
supernatant by absorption at 280 nm (αSN extinction coefficient
5,600 M−1 cm−1). The amount of fibrils was calculated as the
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decrease in mass compared to absorption before fibrillation. The
fibrils were resuspended in the original volume and sonicated
using a Qsonica sonicator with 1/16” tip at 20% intensity with
cycles of 5 s on/5 s off for 1 min. These seeds were added
at different ratios to 1 mg/ml freshly prepared monomer and
incubated on a Varioscan flash plate reader using excitation at
444 nm and emission at 485 nm at 37◦C with a reading every
10 min using bottom optics. To test the effect of extracts or
small molecules, 1 µl plant extract or 30 or 150 µM of the
tested compound was added to the solution containing 1 mg/ml
monomeric αSN and 5% seeds.
Oligomer Preparation
This was carried out on an ÄKTA Basic system. Solutions of
3 mg/mL of αSN were incubated on a shaking incubator for
5 h at 37◦C. The solution was then filtered and separated on
a 20 cm Superose 6 column with PBS buffer at a flow rate of
0.5 mL/min, while monitoring absorbance at 215 nm. Oligomers
were collected in 0.5 mL fractions and concentrated in 15 mL
Amicon spin filters with a 10 kDa cut-off (the αSN oligomer has
an average mass of ca. 420 kDa; Lorenzen et al., 2014a).
Calcein Release
Calcein-filled vesicles were prepared by suspending 10 mg/mL
of DOPG and 40 mM calcein in milliQ water. The solution was
then frozen in liquid nitrogen, thawed in a water bath 10 times,
and extruded 20 times through a 200 nm filter. The solution was
passed over a PD 10 column (GE Healthcare Europe GmbH,
Brondby, Denmark), the progress of the solution through the
columns was observed and fractions were collected when the first
colored solution came through the column. The first 0.5 mL was
discarded and the second 0.5 mL was collected for the assay. We
estimate the vesicle concentration in this fraction to be 5 mg/ml.
The final concentration of oligomer in calcein assays was
0.029 mg/ml (2 µM in monomer αSN equivalents); 5 µL of
extract, or fractionated extract equivalent in amount to 5 µL of
the original extract, was mixed with oligomer solution to 148 µL,
incubated for 1 h, after which 2 µL of calcein-filled vesicles was
added. Immediately after mixing, fluorescence F0 was measured
on a Varioskan Flash fluorimeter (Thermo Scientific) with
excitation at 495 nm and emission at 515 nm, 5 nm bandwidth,
and 100 ms measurement using top optics with autorange. After
40 min measurement, fluorescence F40 was recorded, 1 µL of
1% Triton X-100 was added to each well to ensure complete
vesicle lysis, and the fluorescence was allowed to stabilize over
10 min after which Ffinal was recorded. The calcein release R was
calculated as follows:
R = (F40 − F0)/(Ffinal − F0)
UHPLC-MS Analysis
Ultrahigh-performance liquid chromatography-mass
spectrometry (uHPLC-MS) was recorded with an Ultimate 3000
RS uHPLC system, equipped with a DAD-3000 photodiode array
detector, coupled to an LTQ-Orbitrap Elite mass spectrometer
(Thermo Scientific, Germany). UHPLC separation was carried
out using a reversed-phase C18 Hypersil gold column (1.9 µm,
30 mm × 2.1 mm i.d., Thermo, Hemel Hempstead) which was
maintained at 35◦C. The solvent system consisted of water/0.1%
formic acid (A) and acetonitrile/0.1% formic acid (B). Separation
was carried out in 30 min under the following conditions:
0 min, 0% B; 27 min, 70% B; 28 min, 100% B. The flow rate
was 0.3 mL/min and the injection volume was 10 µL. Mass
spectra were collected using an LTQ-Orbitrap Elite with a heated
ESI source (Thermo Scientific, Germany). Mass spectra were
acquired in negative mode with a resolution of 120,000 over m/z
50–1,500. The source voltage, sheath gas, auxiliary gas, sweep
gas, and capillary temperature were set to 2.5 kV, 35 (arbitrary
units), 10 (arbitrary units), 0.0 (arbitrary units), and 350◦C,
respectively. Default values were used for other acquisition
parameters. Automatic MS-MS was performed on the three most
abundant ions and an isolation width of m/z 2 was used. Ions
were fragmented using high-energy C-trap dissociation (HCD)
with a normalized collision energy of 65 and an activation time
of 0.1 ms. Data analysis was carried out using Xcalibur v. 2.2
(Thermo Scientific, Germany).
CD Spectroscopy
To study whether the identified small molecules affect the binding
of αSN to vesicles, 14 µM monomeric αSN was incubated
with 0.3 mM vesicles of DMPG of size 100 nm (prepared by
extrusion as described in Kjær et al., 2009) in the presence
of small molecules (40 µM) identified from the plant extract.
Temperature scans were recorded as changes in ellipticity at
222 nm with a scanning speed of 60◦C/h on a Jasco J-810
spectrophotometer (Jasco Spectroscopic Co., Ltd., Hachioji City,
Japan) using a 1-mm cuvette (Kjær et al., 2009).
Cell Viability Assay
The MTT assay was used to measure the cell viability after
24 h treatment with monomeric or aggregated form of αSN.
OLN-93 cells were seeded in 96-well plates at a density of
3 × 104 cell/ml in RPMI 1640 supplemented with 10% FCS,
100 units/ml penicillin, and 100 µg/ml streptomycin. The cells
were incubated in a humidified atmosphere incubator with 5%
CO2 and 95% humidity at 37◦C for 24 h. Media was then
replaced with fresh media containing 10% αSN samples with
or without compounds (collected during the fibrillation process)
and incubated for more 24 h. Then the media was replaced with
fresh media containing 10% MTT (5 mg/ml) and the cells were
incubated for an additional 4 h at 37◦C. As a final point, the MTT
solution was removed and replaced by 100 µl DMSO in order
to dissolve formazan crystals through incubating for 1 h on a
shaking table at room temperature. Ultimately, absorbance was
determined by using a plate reader at 570 nm.
ROS Assay
To assess whether αSN aggregates could interfere with the level
of ROS within the cells, DCFH-DA was used. OLN-93 cells were
seeded in 96-well plates at a density of 6 × 104 cells/ml and
incubated in a humidified atmosphere incubator at 37◦C for 24 h.
The media were then removed and the cells washed with PBS
and renewed with PBS containing 15 µM DCFH-DA. The plate
was incubated for 45 min in dark in CO2 incubator. DCFH-DA
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was then removed and the wells were washed with PBS. The cells
were then treated with culture media containing αSN aggregates
and incubated at 37◦C. The fluorescence intensities of DCF
were then recorded using an automatic microtiter plate reader
(emission/excitation: 490/527 nm).
RESULTS
Proteins From Acer saccharum Form
Fibrils Upon Prolonged Incubation
Unless Small-Molecule Plant Extract Is
Added
Our hypothesis posits that plants do not form fibrils because
they contain inhibitors. As a test case, we selected A. saccharum,
both for reasons of availability and convenience and because it
later turned out to provide the best extract to inhibit protein
aggregation (see below). We decided to sample the leaves of this
organism as well as the many other organisms which we later
examined, given their easy accessibility and the possibility to
carry out uniform sampling for all plants. We acknowledge that
leaves constitute a short-lived part of the plant unlike persistent
tissue such as the shoot or root apical meristem, making their
relevance questionable in terms of longevity studies. However,
data from leaves would at worst constitute a false negative, and
thus any evidence for anti-aggregative properties even in such
ephemeral organs could be considered a robust observation.
Proteins were crudely fractionated according to size by gel
filtration (Supplementary Figure S1A). Partial fractionation
was confirmed by concentrating the fractions by ultrafiltration
followed by SDS-PAGE analysis (Supplementary Figure S1B).
To test for the different fractions’ ability to fibrillate, we used
conditions known from other experiments to favor protein
aggregation under otherwise mild conditions (neutral pH and
37◦C), namely, prolonged and vigorous shaking (Giehm and
Otzen, 2010, 2012). The formation of fibrils was followed over
time using the compound ThT, whose fluorescence increases
significantly when bound to amyloid (Naiki et al., 1989). ThT
fluorescence increased for some protein fractions over a 5-day
incubation period (Supplementary Figure S2), consistent with
general formation of fibrils (data for protein fraction 27 shown
in Figure 1A and the remaining fractions in Supplementary
Figure S2). There were no fibrils in F27 before extraction
according to TEM (Figure 1B, left), but fibril-like structures were
observed after 5 days of incubation [Figure 1B(I)]. We then
tested whether an unfractionated small-molecule A. saccharum
extract (here defined as species that could be extracted in
acetone, redissolved in water, and passed through a 3 kDa
filter) could inhibit this fibrillation. Although the extract was
diluted 15-fold, it completely suppressed growth of the ThT signal
(Figure 1A), and the absence of fibrils was confirmed by TEM
images (Figure 1B, right). Similar results were obtained with
Abies nordmanniana (Nordmann fir, data not shown).
We also examined A. saccharum’s population of protein
aggregates (i.e., proteins not solubilized in the normal extraction
process) for the possible presence of fibrils. The TEM image
shows amorphous aggregates but no fibrils (Figure 1C) and the
ThT showed no fluorescence intensity when it was added to the
aggregates (data not shown).
Acetone Was Selected as the Best
Solvent to Extract Small Molecules From
the Plant Leaves
To select the best solvent to extract small molecules from the
plant leaves, we tested the inhibitory effect of extracts obtained
with different solvents on the aggregation of the amyloidogenic
protein αSN, whose aggregation is central to the development
of Parkinson’s disease (Volles and Lansbury, 2003). The extract
made with 100% acetone turned out to completely suppress the
ThT signal (Figure 2A) and was also accompanied by a complete
lack of fibrils according to TEM (Figure 2B). In contrast, αSN
incubated without extract produced a large quantity of straight
FIGURE 1 | Fibrillation of proteins in extracts from A. saccharum. (A) Demonstration of fibrillation of f27 proteins (black line) compared to the inhibition of the
fibrillation by small molecule extract of A. saccharum (red-brown line) through Thioflavin T fluorescence. Soluble proteins extracted from A. saccharum were
size-fractionated by gel filtration and incubated over 0–5 days. The fibrillation data for the other fractions are shown in Supplementary Figure S2. (B) TEM images
of f27 proteins recorded under different conditions: before incubation (I) and after 5 days at 37◦C without (II) or with small molecule extract of A. saccharum (III). Scale
bar, 200 nm. (C) TEM images of protein aggregates extracted from A. saccharum leaves confirm very low amounts of fibrils.
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FIGURE 2 | Inhibition of αSN fibrillation by different small-molecule extracts from A. saccharum. (A) αSN fibrillation assessed by thioflavin T fluorescence during
prolonged incubation in the absence and presence of extracts made using 100% acetone, 80% acetone – 20% water, 100% ethanol, and 50% ethanol – 50%
water. TEM images of αSN samples incubated (B) in the presence of acetone extract and (C) just in buffer confirm that the plant extract inhibits protein fibrillation.
Scale bar: 200 nm.
unbranched fibrils (Figure 2C). We found that the plant extract
causes some ThT signal quenching at the used concentration
(data not shown). However, while the absolute values of the
ThT signal cannot be used as a quantitative measure of the
extent of fibrillation, it is reasonable to use changes in the time
course of ThT fluorescence as an indication of interference with
fibrillation. Accordingly, further analysis of fibrillation based on
ThT fluorescence was based on the lag time preceding growth of
ThT fluorescence.
Ranking of Broad Ranges of Plant
Samples Based on Their Potential to
Inhibit αSN Fibrillation
To investigate the inhibitory effect of extracts across a broad
range of plant samples, we prepared extracts from 29 different
plants spanning a large part of the plant kingdom and available
from the Aarhus Botanical Gardens (Figure 3A). Samples were
obtained from approximately the same wet mass of plant
material (typically leaf tissue), making it possible to make a
rough comparison based on the biological concentration of
these materials; 10 µl of these extracts were then tested for
their ability to inhibit aggregation of αSN in ThT plate reader
assays. Increasing the volume to 100 µl led to a zero ThT
signal in all samples tested, but EM imaging showed that fibrils
were still present in similar amounts to the control for the
samples previously characterized as non-inhibitors, though they
were absent from those characterized as partial inhibitors (data
not shown). Therefore, we limit ourselves to analysis at low
extract concentrations.
Some of the extracts caused complete inhibition of fibrillation
over a 48-h period (as verified by EM, data not shown),
and other caused significantly increased lag times (see below).
We carried out additional sampling from the more promising
subgroups, and added more control samples, to bring the total
number of sampled plants up to 49 (Supplementary Table S1).
For practical reasons (season-dependent harvesting of samples),
several analyses were limited to the original 29 samples. There is
a strong correlation between the maximum attainable age for the
plant and the inhibitory effects (Figure 3A). This is quantified
in Figure 3B which shows that only 30% (3 out of 10) of the
plants that live less than a decade had an anti-fibrillatory effect;
this number rises to 45% (5 out of 11) for those that live for
decades, and 91% (21 out of 23) for those that live for centuries.
The percentages showing strong inhibition were 20, 18, and 70%
for years, decades, and centuries, respectively, also emphasizing
the superior performance of long-lived plants. Partial inhibition
was most common in decades old plants (27.2%) followed by
centuries-old plants (22%) and least prevalent among the plants
that only live for years (10%).
To identify which extracts were the most efficient, we
carried out αSN fibrillation assays for dilutions of the four
extracts that showed no fibrillation according to EM or ThT
fluorescence. Extracts were dried and weighed to be able
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FIGURE 3 | Correlation between plant longevity and ability to inhibit fibrillation. (A) Evolutionary relationships between the screened plants as indicated by the NCBI
phylogeny database with family indicated. Subcategories are indicated only when they are needed to categorize the tested plants as belonging to the same group,
for example the subgroups for sphagnum are not shown because its only point of commonality with the other plants belongs to Steptophyta s11. Plants yielding
extracts that were strongly inhibitory are indicated in black, partially inhibitory in gray, and those having no effect in white. Each plant’s maximum attainable age is
listed as either years (yellow), decades (red), or centuries (purple). (B) The data from A illustrated as a bar graph, showing the number of plant showing no inhibition
(red), partial inhibition (blue), and strong inhibition (green) for plants that live for years, decades, and centuries, respectively.
to rank them in terms of effect per weight (Table 1). We
found that A. saccharum was the most efficient, followed by
A. saccharinum. The next two on the list, E. globolus and
P. menziesii, were both significantly less efficient. Time courses
for the effect of these extracts on αSN fibrillation are shown in
Figure 4A. For comparative purposes, we include the amount
of material required to cause complete inhibition of the ThT
fluorescence signal relative to that of EGCG, one of the most
efficient general inhibitors of fibrillation (Ehrnhoefer et al., 2008).
Remarkably, the two Acer extracts are significantly more efficient
than EGCG on a per-mass basis, in contrast to E. globolus
and P. menziesii.
The ability of the extracts of A. saccharum, A. saccharinum,
and E. globolus to prevent the seeding of αSN fibrillation
by sonicated fibrils was tested by adding plant extract to
the seeds and incubating for 24 h before adding them to
the monomer (to provide time for possible dissociation or
remodeling of the seeds). Addition of seeds to monomeric
αSN without any extracts abolished the ∼8-h lag phase
of fibrillation as expected (Figure 4B); extracts from
A. saccharinum and E. globolus restored the 8-h lag phase
and reduced the final ThT level, while A. saccharum extract
completely suppressed fibrillation, emphasizing its preeminence
as aggregation inhibitor.
To examine whether these inhibitory effects extended to
other aggregating proteins and peptides, we turned to the Aβ40
peptide involved in Alzheimer’s disease. We found inhibitory
effects for all of the highly effective αSN fibrillation inhibitors
(Figure 5A). Both A. sacharum and A. saccharinum totally
inhibited Aβ40 fibrillation at 10 µL per well, extracts of
P. menziesii caused delayed and decreased fibrillation and
E. globolus extract only reduced ThT fluorescence end point
levels but with the same lag time. Further studies with
P. menziesii were discontinued because of relatively weak effects
compared to the Acer species and limited availability. For
additional support, we examined the amyloidogenic peptide
amylin involved in type 2 diabetes. Also here, as little as
1 µl of both Acer species and E. globolus extracts were all
very efficient at reducing amylin fibrillation as followed by
ThT-fluorescence (Figure 5B).
Identification of Specific Inhibitory
Compounds by Fractionation
The A. saccharum extract showed the most pronounced
inhibitory effect on fibrillation of both αSN, Aβ, and amylin.
To identify which compounds were responsible for this,
the extract was fractionated by reverse phase HPLC on
a Jupiter C18 column (Figure 6A), and the 15 resultant
fractions were individually tested in an αSN fibrillation
assay (Supplementary Figure S3). The total level of ThT
fluorescence was dramatically decreased in the presence of
several of these compounds (summarized in Figure 6B),
particularly fractions 2–11. To provide a complementary analysis
of the compounds’ effects, we measured their ability to
prevent or reduce the αSN oligomer’s permeabilization of
phospholipid vesicles through release of calcein. The αSN
oligomer is known to perturb anionic phospholipid vesicles,
allowing eﬄux of small molecules trapped within the vesicle;
aggregation inhibitors such as EGCG are able to prevent this
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FIGURE 4 | Effect of extracts from the four indicated plants on αSN fibrillation. (A) Fibrillation of 1 mg/ml αSN in the presence of 0–10 µl of extracts and (B) fibrillation
of 1 mg/ml monomeric αSN fibrillation alone (black), in the presence of 5 or 10% pre-existing seeds (gray) or in the presence of 5% seed and 1 µl plant extract
(colored points). Incubation at 37◦C in 100 mM Tris pH 8.5 with one glass bead, 12-min cycles including 10-min orbital shaking followed by reading of fluorescence.
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FIGURE 5 | (A) Inhibition of fibrillation of 40 µM Aβ by 0–10 µl of extracts and (B) 10 µM amylin by 1 µl of extracts from the four indicated plants. In both cases,
incubation at 37◦C in 100 mM Tris pH 8.5 without shaking and reading every 10 min.
by binding to the oligomer and reducing its membrane affinity
(Lorenzen et al., 2014b). In this assay, particularly fractions
4–10 as well as fraction 13 showed remarkable efficiency
(Figure 6C), giving reasonable though not complete overlap
with ThT data.
Finally, we used high-resolution UHPLC-MS in negative
ion mode to identify individual compounds in the individual
A. saccharum fractions. This revealed that each of the analyzed
fractions contained multiple compounds. MS-MS analysis and
comparison of retention times to authentic standards were used
in combination for structural determination (Supplementary
Table S2). For fractions 3–6, the total ion chromatograms
(Figure 6D) included major peaks for a range of known
compounds including catechin and epicatechin ([M-H]− at m/z
289, C15H13O6) appearing at 14.28 and 16.8 min, respectively,
and dimeric catechin procyanidin B isomers ([M-H]− at m/z
577, C30H25O12) which were characterized by an MS-MS
fragment at m/z 289. Peaks 4 and 10 (m/z 633) corresponded
to metabolites with a molecular formula of C27H22O18 and
MSMS fragmentation displayed fragment ions (m/z 463, 301,
and 169) suggestive of isomers of galloyl-hexahydroxydiphenoyl-
glucose. This is a well-known ellagitannin found in numerous
plant species (Iranzo, 2011) including A. saccharum. The
fragment m/z 463 relates to M-H-galloyl while fragments
at m/z 301 and 169 relate to ellagic acid and galloyl
entities, respectively. MS-MS fragmentation patterns of peak
9 (m/z 647) included an additional ion at m/z 433 having
a formula of C19H13O12 which was indicative of an ellagic
acid xyloside derivative. Peaks 11 (m/z 517.5) and 13 (m/z
516.5) were doubly charged and corresponded to compounds
with molecular weights of 1,036 and 1,034, respectively. The
identity of these peaks could not be determined although
MS-MS spectra of these ions both included an ion at m/z
169 which corresponded to the known gallic acid fragment
(C7H5O5), further indicating that a range of galloylated
derivatives were present across the fractions, the majority
appearing in fraction 6. Unlike other entities which appeared
in specific fractions, the known fibrillation inhibitor chlorogenic
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FIGURE 6 | Fractionation of A. saccharum extract to identify inhibitors. (A) UV absorbance of the reverse phase fractionation over a Jupiter C18 RP-HPLC column of
the small molecule extract in red, with fractions 1–16 indicated in blue. (B) Normalized ThT fluorescence of αSN fibrillation in the presence of the fractions defined in
Figure 5A based on raw data shown in Supplementary Figure S3. (C) Membrane permeability assay: Normalized release of calcein by 2 µM αSN oligomers with
or without pre-treatment with 5 µL extract equivalent of fractionated A. saccharum extract. All extracts have been verified not to cause calcein release without
oligomer (not shown). (D) Total ion chromatograms from LC-MS (negative ion mode A) chromatography used to identify active components within inhibitory
fractions. Numbers refer to compounds in Supplementary Table S2.
acid [23,24] (with [M-H]− at m/z 353, C16H17O9) appeared
in each chromatogram at 14.9 min with highest levels in
fractions 4 and 5. This metabolite was assigned by a strong
MS-MS fragment at m/z 191 (C7H11O6) relating to the quinate
moiety and via comparison of its retention time to that of an
authentic standard.
Although several of the inhibitory fractions contained
chlorogenic acid, fractions 7–11 contain no chlorogenic acid,
yet still show strong inhibitory effects (Figure 6B). Analysis
of the LC-MS data of these fractions showed that there were
no major metabolite peaks that were consistently present
in all of these fractions (Figure 6B). While the total ion
chromatogram of fraction 7 contained peaks which overlapped
with those of fraction 6, fraction 8 and 9 were dominated
by a peak with m/z at 468 (19.25 min). This ion was again
doubly charged and related to a molecule with a formula of
C41H30O26, the [M-H]− ion at m/z 937 being clearly visible
in the MS spectrum. The identity of this peak was assigned
to a trigalloyl-hexahydroxydiphenoyl-glucose derivative such as
Davidiin, an ellagitannin previously reported to be present in
A. saccharum (Hatano et al., 1990). Fractions 10 and 11 also
each contained differential peaks to those of earlier fractions
with fraction 11 being dominated by pentagalloyl glucose
appearing at 21.55 min.
Effect of Identified Plant Compounds on
αSN Aggregation
Based on the LC-MS data in combination with the known
literature, we selected five compounds (procyanidin B2,
pentagalloylglucose, ellagic acid, chlorogenic acid, and catechin)
for more detailed studies on their effects on αSN structure
and aggregation. We started by interrogating the compounds’
ability to affect the interaction of monomeric αSN with
DMPG vesicles. When αSN is added to DMPG vesicles, it
undergoes a transition to a structure rich in α-helical structure.
When each of the small molecules (40 µM) was titrated
into a solution of αSN and DMPG, this helical structure
is maintained (Supplementary Figure S4), suggesting that
the compounds cannot displace the protein from the lipid
membranes and reduce the α-helical content of αSN. Thus,
they do not directly reduce monomeric αSN’s interaction
with membranes.
Subsequently, we addressed the inhibitory effect of
10–150 µM of the compounds on aggregation of αSN as
monitored by a ThT-binding assay. All compounds had
an inhibitory effect, but they varied significantly in their
potency; only pentagalloylglucose inhibited fibrillation
completely at 75 µM, similar to the internal control
EGCG, whereas the rest of the compounds only inhibit
weakly (Figure 7A).
To determine whether or not the compounds can
affect the secondary pathway of αSN, we used seeding
to bypass the primary nucleation, adding short sonicated
fibrils to monomeric αSN to accelerate the nucleation
phase of amyloid formation. In all cases, 30 and 150 µM
of the tested compounds inhibited fibril formation.
Notably, the inhibitory effect of pentagalloylglucose
was higher than other compounds and comparable to
EGCG (Figure 7B).
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FIGURE 7 | (A) The effect of the identified compounds (10–150 µM) on αSN fibrillation. (B) The effect of the identified compounds (30 and 150 µM) on the seeding
of αSN aggregation.
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Next, we examined the ability of the compounds
to change the membrane permeabilization by αSN
oligomers using calcein-loaded DOPG vesicles. The
permeabilization of phospholipid membranes by αSN
oligomers may be considered a simple proxy for
cellular toxicity (Lorenzen et al., 2014b). Oligomers
were pre-incubated with compounds and then added
to the vesicles. Oligomer-induced calcein release was
significantly inhibited by pentagalloylglucose and EGCG
even at 0.5 µM, but only weakly inhibited by the rest of
the compounds (Figure 8A).
To determine the effect of the compounds on the formation
of toxic aggregates during the fibrillation process over
different times (0–24 h), we conducted an MTT and a
ROS assay with OLN-93 cells. The MTT assay (Figure 8B)
showed that αSN aged in the absence of the compounds
decreased cell viability up to 8 h, after which the deleterious
effect on cell viability decreased, consistent with the view
that cytotoxic oligomers accumulate in the early stages of
protein aggregation (Bucciantini et al., 2002). In contrast,
aggregates resulting from the incubation of αSN with EGCG,
procyanidin B2, pentagalloylglucose, and chlorogenic acid
were significantly less toxic. The decreased toxicity could be
due to the removal of toxic aggregates and their conversion
to other aggregates or a reduction of their ability to bind
to cellular membranes as suggested by the calcein-release
experiments (Figure 8A).
To evaluate the ROS production values in OLN-93 cells,
the cells were exposed to αSN aggregates formed with and
without compounds. We saw a significant decrease in the level
of ROS production of cells exposed to the aggregates of αSN
incubated with the compounds at different times (Figure 8B).
Interestingly, the level of ROS production in the presence of
the aggregates remained essentially constant throughout the
aggregation process.
DISCUSSION
This study has attempted to link plant longevity with the
presence of anti-aggregative compounds. We would like to
make the important disclaimer that we do not consider the
ability of small molecule plant metabolites to inhibit unwanted
protein aggregation to be the predominant evolutionary driving
force in the development and regulation of these compounds.
Plant longevity is determined by an enormous array of
different factors which will contribute to different extents,
and the small molecules we have identified as inhibitors
FIGURE 8 | (A) Calcein release from DOPG vesicles in the presence of 2.5–10 µM of the different compounds. (B) Viability (MTT assay) and (C) ROS production of
OLN-93 cells after 24 incubation with αSN aggregates formed alone and in the presence of the compounds.
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serve a multitude of different functional purposes in plant
physiology, many of which are unrelated to aggregation.
It is also natural to expect that plant proteins have been
selected both for their biological function and for their
ability to avoid unwanted aggregation, as is known in
proteins from many other organisms, cfr. gatekeeper residues
(Otzen et al., 2000; Rousseau et al., 2006). Furthermore,
our approach does not do justice to compartmentalization
and distribution of small molecules and proteins within the
cell which is lost upon extraction and is not recreated in
our very simplistic inhibition assays. It could, however, be
hypothesized that it would be useful for plants to produce
and maintain small molecules which in addition to their
intrinsic metabolic functions also suppress unwanted aggregation
of proteins, and that such properties could contribute (in,
however, modest a way) to the extension of plant life
times. Strong proof of a causal relationship between anti-
aggregative properties and longevity is very difficult to establish
and is far beyond the scope of the present study, but
our rather naïve attempts to establish a correlation between
anti-aggregative properties and longevity are not inconsistent
with such a relationship. At the very least, our observations
constitute an empirical basis for more systematic attempts
to go treasure-hunting in the vast collection of natural
plant compounds for compounds against aggregation-driven
neurodegenerative diseases.
With these caveats in mind, we cautiously speculate on
the possible role of anti-aggregators in plants. At the start
of this project, we considered two reasons to explain the
absence of endogenous plant protein fibrils. Either the proteins
have low intrinsic fibrillation propensities or there is a
mechanism for inhibiting fibrillation. We tested the intrinsic
fibrillation propensity by purifying and incubating soluble plant
proteins, and found that multiple semi-purified A. saccharum
protein fractions fibrillate quite readily upon shaking, ruling
out intrinsic low fibrillation propensity. This left fibrillation
inhibition as the most likely explanation (ruling out less
likely mechanisms such as a plant pathogen response or the
presence of physical barriers like the cell wall). Therefore,
we added A. saccharum small molecules back to the protein
mix and found that this efficiently inhibited fibrillation. It
is also clear that we have not caused conditions where all
the proteins fibrillate, as many other structures are present
in the EM pictures. The fact that the same small molecules
extracts inhibit the fibrillation of unrelated pathogenic proteins
such as αSN, Aβ40, and amylin is strong evidence that these
small molecules are key to the absence of protein fibrillation
in Acer saccharum.
From here, the target was to show if the ability to inhibit
fibrillation was broadly distributed in the plant kingdom, and
we therefore extracted small molecules from a broad range of
plants. Here, we observed that inhibitory effect are generally
stronger for the longer lived plants, though there are both
long-lived plants which do not function as inhibitors, and short-
lived plants which function well. We do, however, see strong
inhibitors in all the branches of the tree of life, though the
age connection seems weaker in the grasses. This could be
because grasses in general senesce their flowering stems at
the end of the growing season, and therefore while the plant
may live for decades, the individual biomass does not, and
inhibition may therefore not be required. In future work, this
could potentially be tested by including palm trees which are
both monocots and have long living persistent tissue. It may
appear that the conifers have a better inhibition than other
branches, though this may also reflect the fact that the conifers
are all long lived. Disregarding conifers, we still find 55% strong
inhibitors, 27% partial inhibitors, and 18% non-inhibitors for
the century old plants, whereas 70% of the plants that live
less than a decade and 54.54% of those that live for decades
have no measurable inhibitory effect. This means that we see
a stronger inhibitory effect for the longer lived plants, which
suggests that this is an effect that is selected for as plants grow
older. Nevertheless, this raises the question why leaves from
some long-lived plants such as Citrus sinensis (orange) and
Quercus robur (oak) do not show inhibitory activity? In the
absence of concrete data, we speculate that there is a higher
concentration in longer lived tissue; oak loses its leaves each
year and citrus trees are prone to large scale leaf loss under
a number of conditions; in other words, leaf extracts could
constitute false negatives because they are not representative
of the entire physiology of the organisms. Added to this the
concentration in the actual tissue is at least 15-fold higher than
in our assay, so it is entirely possible that there is an inhibitory
effect at physiological concentrations.
From an evolutionary standpoint, it is very interesting that
a number of short lived plants inhibit protein fibrillation.
This suggests both that fibrillation inhibition is endemically
present in nearly all plants, but not present in effective
concentrations in those plants where evolutionary pressure
does not select. Note also that the inhibitors already identified
also have different metabolic functions. Thus, EGCG is a
cell wall regulating component (Lewis et al., 2008), while
chlorogenic acid, an aggregation inhibitor identified both here
and elsewhere (Cheng et al., 2011; Wei et al., 2016) is
part of the lignin metabolism (Taylor and Zucker, 1966). In
many cases, only a few mutations can be required for an
organism to increase the amount of an existing metabolite
molecule (e.g., a single point mutation in the promotor
of a single gene coding for a biosynthetic enzyme). Given
the variety of plant metabolites and biosynthetic pathways,
it could be imagined that a plant species in this way
could frequently accumulate mutations which would mitigate
protein fibrillation and promote longevity. The mutations
would then be retained, provided they had no serious
negative repercussions.
CONCLUSION
The fibrillation of native proteins has not been observed in plants;
here we show that this is due to the presence of fibrillation
inhibitors in nearly all plants that live longer than a century.
This inhibitory effect is the result of numerous different small
molecules. These cocktails of small molecules contain known
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inhibitors, and are by weight more efficient than most of the
known fibrillation inhibitors. The broad range of extracts found
during our screening, and the remarkable success rate (91% at
least partial inhibitors for plants with centuries-long lifespans)
indicate that there should be great potential for identification of
non-toxic effective inhibitors from the plant kingdom.
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